Globus Medical EBITDA 2010-2024 | GMED

Globus Medical annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Globus Medical EBITDA for the quarter ending March 31, 2024 was $0.124B, a 64.83% increase year-over-year.
  • Globus Medical EBITDA for the twelve months ending March 31, 2024 was $0.407B, a 30.65% increase year-over-year.
  • Globus Medical 2023 annual EBITDA was $0.359B, a 18.87% increase from 2022.
  • Globus Medical 2022 annual EBITDA was $0.302B, a 23.3% increase from 2021.
  • Globus Medical 2021 annual EBITDA was $0.245B, a 39.86% increase from 2020.
Globus Medical Annual EBITDA
(Millions of US $)
2023 $359
2022 $302
2021 $245
2020 $175
2019 $224
2018 $213
2017 $207
2016 $200
2015 $200
2014 $163
2013 $123
2012 $133
2011 $114
2010 $103
2009 $95
Globus Medical Quarterly EBITDA
(Millions of US $)
2024-03-31 $124
2023-12-31 $142
2023-09-30 $57
2023-06-30 $85
2023-03-31 $75
2022-12-31 $72
2022-09-30 $79
2022-06-30 $86
2022-03-31 $65
2021-12-31 $36
2021-09-30 $71
2021-06-30 $66
2021-03-31 $72
2020-12-31 $76
2020-09-30 $66
2020-06-30 $-10
2020-03-31 $43
2019-12-31 $64
2019-09-30 $55
2019-06-30 $55
2019-03-31 $49
2018-12-31 $55
2018-09-30 $49
2018-06-30 $53
2018-03-31 $56
2017-12-31 $58
2017-09-30 $47
2017-06-30 $49
2017-03-31 $54
2016-12-31 $57
2016-09-30 $46
2016-06-30 $46
2016-03-31 $50
2015-12-31 $63
2015-09-30 $48
2015-06-30 $44
2015-03-31 $45
2014-12-31 $46
2014-09-30 $41
2014-06-30 $38
2014-03-31 $38
2013-12-31 $38
2013-09-30 $35
2013-06-30 $17
2013-03-31 $34
2012-12-31 $34
2012-09-30 $32
2012-06-30 $35
2012-03-31 $32
2011-12-31 $28
2011-09-30 $31
2011-06-30 $28
2011-03-31 $27
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.027B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.815B 26.27
Intuitive Surgical (ISRG) United States $152.521B 91.88
Edwards Lifesciences (EW) United States $52.348B 34.07
DexCom (DXCM) United States $46.342B 70.20
Alcon (ALC) Switzerland $43.615B 31.25
IDEXX Laboratories (IDXX) United States $41.651B 48.82
IQVIA Holdings (IQV) United States $38.867B 22.55
STERIS (STE) Ireland $21.364B 24.96
SONOVA HOLDING (SONVY) Switzerland $18.279B 0.00
Waters (WAT) United States $17.455B 25.65
Hologic (HOLX) United States $16.670B 18.65
Fresenius Medical Care AG KGaA (FMS) Germany $11.719B 13.68
Sysmex ADR (SSMXY) Japan $10.095B 31.66
Teleflex (TFX) United States $9.692B 15.09
Penumbra (PEN) United States $7.261B 82.52
Masimo (MASI) United States $7.185B 41.39
Glaukos (GKOS) United States $5.641B 0.00
TransMedics (TMDX) United States $4.713B 447.11
Integer Holdings (ITGR) United States $3.930B 23.75
PROCEPT BioRobotics (PRCT) United States $3.190B 0.00
LivaNova (LIVN) United Kingdom $2.867B 17.03
Tandem Diabetes Care (TNDM) United States $2.777B 0.00
Nihon Kohden (NHNKY) Japan $2.650B 14.04
Inari Medical (NARI) United States $2.513B 0.00
Elekta AB (EKTAY) Sweden $2.397B 18.38
Integra LifeSciences Holdings (IART) United States $2.277B 9.93
RxSight (RXST) United States $2.075B 0.00
Veracyte (VCYT) United States $1.634B 0.00
Alphatec Holdings (ATEC) United States $1.466B 0.00
Artivion (AORT) United States $0.966B 92.68
OPKO Health (OPK) United States $0.871B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.869B 16.91
Silk Road Medical (SILK) United States $0.855B 0.00
OrthoPediatrics (KIDS) United States $0.701B 0.00
Pulse Biosciences (PLSE) United States $0.654B 0.00
IRadimed (IRMD) United States $0.545B 30.52
SiBone (SIBN) United States $0.515B 0.00
Paragon 28 (FNA) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.472B 0.00
Pacific Biosciences Of California (PACB) United States $0.455B 0.00
Treace Medical Concepts (TMCI) United States $0.377B 0.00
Nevro (NVRO) United States $0.328B 0.00
AxoGen (AXGN) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.321B 0.00
Tactile Systems Technology (TCMD) United States $0.279B 9.54
Semler Scientific (SMLR) United States $0.273B 13.85
CVRx (CVRX) United States $0.237B 0.00
AngioDynamics (ANGO) United States $0.236B 0.00
Delcath Systems (DCTH) United States $0.215B 0.00
EDAP TMS S.A (EDAP) France $0.198B 0.00
908 Devices (MASS) United States $0.196B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Accuray (ARAY) United States $0.186B 0.00
Inogen (INGN) United States $0.171B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Yubo Biotech (YBGJ) China $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.086B 18.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
ReWalk Robotics (LFWD) Israel $0.038B 0.00
Lucid Diagnostics (LUCD) United States $0.037B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.022B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00